NPI: 1255419651 · TRENTON, NJ 08629 · General Acute Care Hospital · NPI assigned 11/02/2006
Authorized official KELLY, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | KELLY, MARK (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 11/02/2006 |
Other providers sharing the same authorized official: KELLY, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 128,825 | $7.73M |
| 2019 | 120,677 | $6.83M |
| 2020 | 82,366 | $3.84M |
| 2021 | 128,381 | $5.68M |
| 2022 | 145,874 | $6.52M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 22,835 | 20,114 | $5.66M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 16,688 | 14,514 | $4.78M |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 16,222 | 1,678 | $4.72M |
| G0378 | Hospital observation service, per hour | 4,933 | 3,572 | $3.92M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,949 | 8,905 | $3.25M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,637 | 4,411 | $596K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,181 | 3,946 | $517K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,007 | 1,934 | $334K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12,718 | 3,046 | $316K |
| 90832 | Psychotherapy, 30 minutes with patient | 3,294 | 1,765 | $313K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 443 | 423 | $306K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,045 | 6,310 | $299K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 8,191 | 2,352 | $297K |
| 71046 | Radiologic examination, chest; 2 views | 11,673 | 10,855 | $252K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 16,065 | 13,536 | $252K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 875 | 841 | $234K |
| 96375 | Therapeutic injection; each additional sequential IV push | 8,180 | 7,466 | $220K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,529 | 1,474 | $202K |
| 90863 | 2,979 | 2,363 | $191K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,303 | 1,285 | $174K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 29,316 | 20,674 | $164K |
| OP272 | 1,938 | 1,631 | $154K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,187 | 1,121 | $144K |
| OP710 | 2,119 | 2,046 | $132K | |
| 80053 | Comprehensive metabolic panel | 23,132 | 19,170 | $115K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7,584 | 7,102 | $114K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5,512 | 5,002 | $109K |
| OP370 | 1,877 | 1,812 | $101K | |
| 93458 | 91 | 88 | $93K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 9,745 | 9,005 | $93K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 704 | 685 | $84K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4,193 | 3,728 | $81K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 382 | 366 | $74K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,811 | 1,710 | $64K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,201 | 3,008 | $64K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,556 | 2,331 | $62K |
| 84484 | 10,972 | 8,764 | $60K | |
| 73130 | 1,322 | 1,280 | $59K | |
| 73030 | 1,106 | 1,070 | $57K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,893 | 1,724 | $56K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,420 | 416 | $54K |
| 73630 | 1,234 | 1,209 | $54K | |
| OP250 | 13,280 | 6,418 | $50K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,851 | 514 | $49K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7,492 | 4,649 | $47K |
| 97161 | 1,027 | 964 | $47K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,013 | 5,524 | $46K |
| 97162 | 868 | 833 | $45K | |
| 70486 | 301 | 292 | $45K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 50 | 50 | $43K |
| 73564 | 1,380 | 1,338 | $42K | |
| 83735 | 11,033 | 6,355 | $42K | |
| A9270 | Non-covered item or service | 3,525 | 2,040 | $40K |
| 72110 | 414 | 412 | $40K | |
| 73610 | 900 | 886 | $38K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,650 | 2,527 | $38K |
| 80320 | 3,955 | 3,458 | $38K | |
| 85610 | 13,257 | 11,477 | $37K | |
| 85730 | 12,984 | 11,357 | $37K | |
| 83880 | 2,607 | 2,424 | $35K | |
| J1644 | Injection, heparin sodium, per 1000 units | 6,332 | 2,792 | $33K |
| C1769 | Guide wire | 737 | 682 | $33K |
| 93970 | 239 | 231 | $32K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 769 | 712 | $30K |
| 80061 | Lipid panel | 2,859 | 2,671 | $27K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,188 | 2,129 | $26K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,187 | 2,128 | $25K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,673 | 2,488 | $24K |
| 71045 | Radiologic examination, chest; single view | 3,054 | 2,779 | $23K |
| 93017 | 97 | 96 | $23K | |
| 97164 | 393 | 383 | $22K | |
| 96367 | 1,085 | 1,023 | $21K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 419 | 404 | $21K |
| 84100 | 5,944 | 2,779 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,663 | 4,307 | $19K |
| 96376 | 1,192 | 1,104 | $18K | |
| 87040 | 2,409 | 2,176 | $18K | |
| 83605 | 2,714 | 2,449 | $18K | |
| OP637 | 19,851 | 6,115 | $16K | |
| 83690 | 7,160 | 6,495 | $16K | |
| 76830 | Ultrasound, transvaginal | 182 | 181 | $15K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 104 | 104 | $15K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 55 | 53 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,856 | 2,699 | $15K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,770 | 2,593 | $14K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,129 | 1,083 | $14K |
| 87275 | 3,827 | 3,764 | $14K | |
| 87276 | 3,826 | 3,763 | $14K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,595 | 2,446 | $14K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 469 | 462 | $14K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4,152 | 3,204 | $13K |
| 73110 | 317 | 310 | $12K | |
| 87430 | 4,117 | 4,035 | $12K | |
| 90715 | 1,314 | 1,282 | $12K | |
| 81001 | 10,072 | 9,454 | $12K | |
| 87070 | 4,491 | 4,357 | $11K | |
| 73502 | 217 | 214 | $10K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,438 | 1,357 | $10K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 102 | 98 | $10K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 494 | 453 | $10K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 15 | 15 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 8,664 | 7,828 | $8K |
| 81025 | 7,619 | 7,206 | $8K | |
| 90686 | 650 | 629 | $8K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,479 | 1,262 | $8K |
| J2704 | Injection, propofol, 10 mg | 2,655 | 2,462 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 776 | 409 | $7K |
| 97116 | 805 | 508 | $7K | |
| 93971 | 85 | 81 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,749 | 1,672 | $7K |
| OP259 | 6,715 | 2,340 | $7K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,401 | 1,605 | $7K |
| J3490 | Unclassified drugs | 47,955 | 21,152 | $7K |
| 88312 | 469 | 452 | $7K | |
| 85027 | 1,432 | 855 | $7K | |
| 83520 | 351 | 325 | $7K | |
| 81003 | 5,442 | 5,145 | $6K | |
| 82803 | 607 | 549 | $6K | |
| OP229 | 107 | 104 | $5K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 14 | 12 | $5K |
| 85379 | 2,151 | 2,014 | $5K | |
| 76642 | 29 | 26 | $5K | |
| 74022 | 149 | 146 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,233 | 5,357 | $5K |
| 97165 | 214 | 194 | $5K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,157 | 2,352 | $4K |
| 96368 | 349 | 293 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 211 | 201 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 375 | 352 | $4K |
| 87186 | 676 | 649 | $3K | |
| C9113 | Injection, pantoprazole sodium, per vial | 2,210 | 1,580 | $3K |
| 86850 | 496 | 399 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 382 | 302 | $3K |
| 97535 | Self-care/home management training, each 15 minutes | 228 | 186 | $3K |
| 36415 | Collection of venous blood by venipuncture | 1,006 | 894 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,595 | 1,479 | $3K |
| 82728 | 362 | 337 | $3K | |
| 76801 | 53 | 51 | $3K | |
| 90791 | Psychiatric diagnostic evaluation | 43 | 43 | $3K |
| J2060 | Injection, lorazepam, 2 mg | 1,205 | 848 | $3K |
| 84466 | 386 | 353 | $3K | |
| 86900 | 1,219 | 1,073 | $3K | |
| OP258 | 2,757 | 1,488 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 957 | 412 | $2K |
| Q3014 | Telehealth originating site facility fee | 1,590 | 1,490 | $2K |
| 84703 | 1,428 | 1,354 | $2K | |
| 73080 | 54 | 51 | $2K | |
| 86141 | 218 | 160 | $2K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,998 | 1,743 | $2K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 40 | 24 | $2K |
| 86901 | 1,219 | 1,073 | $2K | |
| 99215 | Prolong outpt/office vis | 70 | 66 | $2K |
| 90670 | 21 | 21 | $2K | |
| 84702 | 472 | 453 | $2K | |
| J3411 | Injection, thiamine hcl, 100 mg | 799 | 592 | $2K |
| 72052 | 25 | 25 | $2K | |
| 77080 | 24 | 24 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 28 | 25 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,056 | 1,658 | $2K |
| 90750 | 16 | 14 | $2K | |
| 73140 | 56 | 53 | $2K | |
| 73590 | 40 | 38 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 28 | 27 | $2K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,142 | 1,995 | $2K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 117 | 116 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,500 | 1,001 | $1K |
| 72100 | 29 | 29 | $1K | |
| 82550 | 534 | 452 | $1K | |
| 87420 | 459 | 452 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,540 | 1,327 | $1K |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 489 | 408 | $1K |
| 90732 | 17 | 17 | $1K | |
| 82010 | 333 | 291 | $1K | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 726 | 712 | $1K |
| 83540 | 371 | 339 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,440 | 1,324 | $1K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 70 | 63 | $1K |
| 12001 | 56 | 56 | $1K | |
| 86803 | 104 | 95 | $954.62 | |
| 82607 | 160 | 140 | $883.70 | |
| 82009 | 263 | 243 | $795.40 | |
| 88313 | 80 | 75 | $786.10 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 232 | 159 | $707.53 |
| 82272 | 76 | 74 | $707.06 | |
| 0012A | 27 | 27 | $655.65 | |
| 87077 | 158 | 147 | $590.76 | |
| 87147 | 232 | 225 | $553.29 | |
| 87220 | 665 | 655 | $516.32 | |
| 80074 | 41 | 37 | $457.50 | |
| J3480 | Injection, potassium chloride, per 2 meq | 448 | 345 | $454.69 |
| 85007 | 83 | 78 | $442.12 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 20 | 20 | $370.38 |
| 82746 | 80 | 75 | $359.01 | |
| 0011A | 28 | 28 | $335.72 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 402 | 258 | $326.91 |
| 71101 | 12 | 12 | $290.86 | |
| 29125 | 40 | 39 | $270.99 | |
| 85651 | 517 | 474 | $266.55 | |
| J1815 | Injection, insulin, per 5 units | 250 | 69 | $229.75 |
| J3370 | Injection, vancomycin hcl, 500 mg | 44 | 26 | $174.88 |
| 88304 | 13 | 12 | $172.94 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 15 | 13 | $127.50 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 18 | 12 | $111.27 |
| G0008 | Administration of influenza virus vaccine | 87 | 87 | $92.30 |
| 80050 | General health panel | 21 | 14 | $90.00 |
| J1956 | Injection, levofloxacin, 250 mg | 54 | 37 | $60.51 |
| 87340 | 12 | 12 | $43.26 | |
| 87205 | 31 | 28 | $40.61 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | 12 | $39.77 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 32 | 12 | $28.23 |
| J3360 | Injection, diazepam, up to 5 mg | 15 | 13 | $24.05 |
| J1940 | Injection, furosemide, up to 20 mg | 56 | 26 | $23.83 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 25 | 13 | $18.16 |
| 85045 | 12 | 12 | $17.00 | |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | 14 | 14 | $13.21 |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | 14 | 14 | $12.01 |
| G0009 | Administration of pneumococcal vaccine | 56 | 55 | $8.18 |
| J7050 | Infusion, normal saline solution, 250 cc | 27 | 12 | $5.62 |
| J7510 | Prednisolone oral, per 5 mg | 58 | 58 | $3.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 29 | 12 | $0.00 |